Background The prognosis of patients with non-small cell lung cancer (NSCLC) is important,
as patients with resectable disease and poor prognostic variables might benefit from …

Purpose This study aimed to evaluate the prognostic value of metabolic tumor burden as
measured with metabolic tumor volume (MTV) and total lesion glycolysis (TLG), as well as …

Purpose We sought to determine whether metabolic volume-based measurements on FDG
PET/CT scans could provide additional information for predicting outcome in patients with …

Introduction To predict the outcome of patients with non-small cell lung cancer (NSCLC) the
currently used prognostic system (TNM) is not accurate enough. The prognostic significance …

Background The recurrence rate for stage I non-small cell lung cancer is high, with 20–40%
of patients that relapse after surgery. The aim of this study was to evaluate new F-18 …

Objectives The aim of this study was to evaluate the usefulness of the tumor burden as
characterized by the metabolic tumor volume (MTV) and total lesion glycolysis (TLG) …

Purpose The aim of the study was to evaluate the prognostic significance of intratumoral
metabolic heterogeneity on pretreatment 18 F-FDG PET/CT in patients with lung cancer who …

Despite the favorable prognosis of stage IA non–small cell lung cancer (NSCLC), the
disease recurs after complete surgical resection in 20%–30% of patients. This study …

Purpose Ratio of maximum standardized uptake value to primary tumor size (SUV
max/tumor size) was previously demonstrated to be a more important indicator of prognosis …

Objective: To evaluate the prognostic significance and predictive performance of volume-
based parameters of 18 F-fluorodeoxyglucose positron emission tomography/computed …